RF Micro Devices Beats Estimates; Exelon Corporation Shares Decline Despite Acquisition


Follow this company

Companies Mentioned

NYSE:EXC / NASDAQ:RFMD / NASDAQ:FXEN / OTC:BB:ELTP
05/01/2014 [ACCESSWIRE]

Exelon Corporation (NYSE: EXC) – For an in-depth report on Exelon Corporation follow: www.BullTrends.com/stockquote/EXC

Shares of Exelon Corporation closed down 3.18% on about 22.5 million shares traded. The stock was one of the biggest decliners on the NYSE despite the company announcing that it would buy Pepco Holdings Inc for $6.83 billion. The acquisition would make the company the biggest power distribution company in the United States.

RF Micro Devices Inc. (NASDAQ: RFMD) - For an in-depth report on RF Micro Devices Inc. follow: www.BullTrends.com/stockquote/RFMD

Shares of RF Micro Devices Inc. closed up 4.33% on about 27.3 million shares traded. The stock was one of the most active on the NASDAQ with an average trading volume of about 10.8 million shares. The company exceeded analysts' expectations in its March-ending quarter. In its first quarter, RF Micro Devices reported adjusted net income of 12 cents a share and revenue of $256 million. Both measures beat estimates. 

FX Energy Inc. (NASDAQ: FXEN) – For an in-depth report on FX Energy Inc. follow: www.BullTrends.com/stockquote/FXEN

Shares of FX Energy Inc. closed up 21.51% on nearly 5 million shares traded. The stock was one of the biggest gainers on the NASDAQ. The gains came after the company reported an estimated production rate of 24 million cubic feet a day (mmcf/d) for its Tuchola field. In a statement the company’s vice president of operations called the flow rates "significantly better than we had hoped." 

Elite Pharmaceuticals, Inc. (OTCBB: ELTP) - For an in-depth report on Elite Pharmaceuticals, Inc. follow: www.BullTrends.com/stockquote/ELTP

Shares of ELTP closed up 13.54% on Wednesday with about 5.2 million shares traded. The stock was one of the biggest gainers in the OTCBB market despite the company not releasing any significant news. On April 22nd, Elite Pharma announced the issuance of U.S. Patent No. 8,703,186 titled "Abuse-Resistant Oral Dosage Forms and Method of Use Thereof". This patent expands the intellectual property for the Company's opioid abuse deterrent technology.

 

Disclosure: BullTrends.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please read our report and visit our website, for complete risks and disclosures.

COMMENTS

Leave a comment...
 * 

Your Name
 *